Edesa Biotech (EDSA) Earnings Analysis

Edesa Biotech (EDSA) next reports earnings on 2026-08-14, consensus EPS -0.44 USD. Last quarter (2026-05-14) it missed with EPS -0.49 USD vs -0.24 USD est (-104.2%). It has beaten estimates in 4/7 recent quarters (57%). Trailing P/E -4.24.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does EDSA next report earnings?

Next earnings date2026-08-14
Consensus EPS estimate-0.44 USD
Revenue estimaten/a

EDSA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-14-0.49 USD-0.24 USD-104.2%Miss
2026-02-13-0.28 USD-0.28 USD0%Beat
2025-12-12-0.32 USD-0.27 USD-18.5%Miss
2025-08-08-0.25 USD-0.26 USD+3.8%Beat
2025-02-14-0.48 USD-0.31 USD-54.8%Miss
2024-12-13-0.29 USD-0.54 USD+46.3%Beat
2024-08-09-0.52 USD-0.58 USD+10.3%Beat

Beat rate: 4/7 (57%) over reported quarters with consensus data.

EDSA valuation and analyst view

Trailing P/E-4.24
Trailing EPS-1.26535 USD
Price / book4.60
Dividend yield0.00%
Market cap0.05B
Analyst consensusBuy (2 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Edesa Biotech (EDSA)'s next earnings date?

Edesa Biotech is next scheduled to report on 2026-08-14, with a consensus EPS estimate of -0.44 USD.

Did EDSA beat earnings last quarter?

In its 2026-05-14 report, EDSA posted EPS of -0.49 USD versus a -0.24 USD estimate — a miss of 104.2%.

What is EDSA's earnings track record?

Over the last 7 reported quarters with consensus data, EDSA beat estimates 4 times (57%).

What is EDSA's current P/E ratio and EPS?

EDSA trades at a trailing P/E of -4.24 on trailing EPS of -1.2653481492879266 USD.

What do analysts rate EDSA?

Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell).